In MS, aberrant TJ regulation, including altered expression and phosphorylation of claudin-5 and occludin, contributes to barrier dysfunction and facilitates immune cell infiltration, which drives neuroinflammation and disease progression [280]. Here, CLDN5 is linked to myeloid sarcoma.